- Home
- MIND vs ONCY Comparison
MIND vs ONCY Comparison
Compare MIND & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIND
- ONCY
- Stock Information
- Founded
- MIND 1987
- ONCY 1998
- Country
- MIND United States
- ONCY Canada
- Employees
- MIND N/A
- ONCY N/A
- Industry
- MIND Industrial Machinery/Components
- ONCY Pharmaceuticals and Biotechnology
- Sector
- MIND Industrials
- ONCY Health Care
- Exchange
- MIND Nasdaq
- ONCY Nasdaq
- Market Cap
- MIND 57.3M
- ONCY 53.6M
- IPO Year
- MIND 1994
- ONCY 1999
- Fundamental
- Price
- MIND $6.00
- ONCY $0.56
- Analyst Decision
- MIND
- ONCY Strong Buy
- Analyst Count
- MIND 0
- ONCY 4
- Target Price
- MIND N/A
- ONCY $4.00
- AVG Volume (30 Days)
- MIND 188.2K
- ONCY 224.8K
- Earning Date
- MIND 04-28-2025
- ONCY 03-07-2025
- Dividend Yield
- MIND N/A
- ONCY N/A
- EPS Growth
- MIND N/A
- ONCY N/A
- EPS
- MIND 6.61
- ONCY N/A
- Revenue
- MIND $45,197,000.00
- ONCY N/A
- Revenue This Year
- MIND $22.98
- ONCY N/A
- Revenue Next Year
- MIND $10.18
- ONCY N/A
- P/E Ratio
- MIND $0.91
- ONCY N/A
- Revenue Growth
- MIND 41.23
- ONCY N/A
- 52 Week Low
- MIND $3.05
- ONCY $0.55
- 52 Week High
- MIND $11.10
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- MIND 32.72
- ONCY 27.91
- Support Level
- MIND $6.61
- ONCY $0.58
- Resistance Level
- MIND $7.23
- ONCY $0.65
- Average True Range (ATR)
- MIND 0.54
- ONCY 0.03
- MACD
- MIND -0.08
- ONCY -0.00
- Stochastic Oscillator
- MIND 18.55
- ONCY 1.34
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.